REG - Wellnex Life Limited - Change of Address

Wellnex LifeAnnouncement

Yesterday 08:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250801:nRSA5852Ta&default-theme=true

RNS Number : 5852T  Wellnex Life Limited  01 August 2025

 

 

 

ASX/AIM
Announcement
1 August 2025

 

Wellnex Life Limited (ASX/AIM:WNX)

 

Change of Address

 

 

Wellnex Life Limited ("Wellnex" or the "Company") (ASX:WNX  AIM:WNX) advises
that it has changed its registered address and principal business address to
the following, effective immediately:

 

BUILDING 2 SUITE 72 LEVEL 3 574 PLUMMER STREET PORT MELBOURNE VIC 3207

 

 

This ASX/AIM announcement has been authorised by the Board of Wellnex Life
Limited (ASX/AIM:WNX).

 

For further information, please contact:

 

Wellnex Life Limited (ASX:WNX)
                                 Reach Markets

George Karafotias or Zack
Bozinovski                           T: 1300 805
9419

Joint Chief Executive
Officers
E: IR@reachmarkets.com.au

P: +61 3 8399 9419

E: george.k@Wellnexlife.com.au (mailto:george.k@Wellnexlife.com.au)

 

UK Investors

 

Strand Hanson (Financial & Nominated Advisor)

James Harris / Richard Johnson / Robert Collins             Tel:
+44 (0) 20 7409 3494

 

Orana Corporate LLP (Joint
Broker)
swykeham@oranacorp.com (mailto:swykeham@oranacorp.com)

Sebastian Wykeham

 

S.P. Angel Corporate Finance LLP (Joint Broker)            Tel: +44
(0)20 3470 0470

David Hignell / Vadim Alexandre

 

About Wellnex Life

Wellnex Life Limited (ASX/AIM:WNX) is a consumer healthcare business with a
track record for developing, licensing, and marketing registered products and
brands to customers in the growing healthcare market segment. Since listing on
ASX in 2021, Wellnex Life has successfully launched a host of brands and
products now ranged in major retailers in the healthcare market space,
pharmacies and supermarkets. Its distribution arrangements have seen Wellnex
Life secure significant licensing arrangements with major pharmaceutical
companies in Australia and globally that have given the Company's registered
products a distribution channel with a steadily increasing global geographic
footprint.

In December 2023, Wellnex Life acquired leading Australian topical pain relief
brand Pain Away. Its addition to Wellnex Life's product offering both
compliments and accelerates the potential growth of the company's business
operations. This transformational acquisition gives added impetus to Wellnex
Life's financial growth and scale and reinforces its place as a major and
respected participant in the growing healthcare market, both in Australia and
overseas.

 

To learn more, please visit: www.Wellnex Lifelife.com.au/
(https://wellnexlife.com.au/)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  CROGZGGRNMFGKZG